Pharma Gladiator to challenge Madras HC order on nimesulide & PPA in Supreme Court
The Pharma Gladiator, an NGO working to eradicate the grievances of pharmaceutical traders in the country, will soon move Supreme Court to challenge the recent Madras High Court order in which the high court has allowed the drug companies to liquidate the stocks of nimesulide suspension and Phenylpropanolamine (PPA), which were recently banned by the union health ministry along with some other drugs that were found to make adverse effects on human health.
“We think the verdict of Madras HC may save the pharmaceutical houses but it it a great loss for the country if the ailing people will be compelled to have those products even for the next 6 months knowing they are having poisons instead of medicines to get prevented or cured from sickness, disease and illness”, said Narendra Jain, chief trustee of Pharma Gladiator (India).
Terming the High Court order as a curse towards humanity, Jain said, “We define ‘Medicine’ is the science and art of healing. It encompasses a variety of health care practices evolved to maintain and restore health by the prevention and treatment of illness. Astonishingly such a verdict of Madras High Court counts to be a curse towards the humanity”.
We expected recall of stock from the market along with ceiling on both sale and production as to be the proper justice from the honourable court. We will file suit for the greater public interest at the apex forum, after intimating the fact to the Human Rights Commission for immediate intervention. Having limited drug trial system in the country, we are already meting out injustice to our countrymen by allowing the marketing of letrozole, levonorestrol, flupentixol-melitracen and several other drugs or formulations, which are banned in several European and neighbouring countries, Jain said. “We will not be surprised if human placentra will be reintroduced in the country”, he said.
“Let the future of the nation remained feeble, paralyzed, fragile but pharmaceutical companies who had adequate opportunity to reduce and also to restrain the production of those deadly weapons, ran after profitability by injecting poisons within the inhabitants of the nation”, said Joydeep Sarkar, managing trustee of Pharma Gladiator.